Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Fernando Martínez-Regueira"'
Autor:
Marta Gimeno-Morales, Laura Motisi, Natalia Rodriguez-Spiteri, Fernando Martínez-Regueira, Tucker Worthington, Vratislav Strnad, Jean Michel Hannoun-Levi, Cristina Gutierrez
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 16, Iss 1, Pp 72-83 (2024)
Externí odkaz:
https://doaj.org/article/903c2edc295c4818ac11ed3210f5fcca
Autor:
Javier-A. Cienfuegos, Jorge Baixauli, Patricia Martínez-Ortega, Víctor Valentí, Fernando Martínez-Regueira, Pablo Martí-Cruchaga, Gabriel Zozaya, José-Luis Hernández-Lizoain
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 110, Iss 11, Pp 684-690 (2018)
ABSTRACT Purpose: the aim of this study was to compare overall and disease-free survival among patients with colorectal cancer detected via a screening program as compared to those with symptomatic cancer. Material and methods: patients diagnosed via
Externí odkaz:
https://doaj.org/article/6642e4c844894b1db8bbed141b790ed5
Autor:
Javier A. Cienfuegos, Fernando Rotellar, Jorge Baixauli, Fernando Martínez-Regueira, Fernando Pardo, José Luis Hernández-Lizoáin
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 106, Iss 3, Pp 171-194 (2014)
Liver regeneration (LR) is one of the most amazing tissue injury response. Given its therapeutic significance has been deeply studied in the last decades. LR is an extraordinary complex process, strictly regulated, which accomplishes the characterist
Externí odkaz:
https://doaj.org/article/7765361ecb7d42718d4ac5af028dcd22
Autor:
Marta Gimeno Morales, Rafael Martínez-Monge, Fernando Martínez-Regueira, Natalia Rodriguez-Spiteri, Begoña Olartecoechea, Luis Ramos, Adriana Ayestarán, Luis Pina Insausti, Arlette Elizalde, Marta Abengozar, Isabel Rubio, Antonio Esgueva, Carolina Sobrido, Mauricio Cambeiro
Publikováno v:
Brachytherapy. 21:475-486
To evaluate the feasibility, early toxicity, and clinical outcomes of early-breast cancer patients in a single-arm, phase I/II study of an ultra-accelerated, four-fraction schedule of minimal breast irradiation (4f-AMBI) using a multicatheter, minima
Autor:
Javier A. Cienfuegos, Pablo Martí-Cruchaga, Gabriel Zozaya, José Luis Hernández Lizoain, Fernando Martínez Regueira, Fernando Pardo, Javier Rodríguez, Leire Arbea Moreno, Fernando Rotellar
Publikováno v:
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.
Although neoadjuvant chemoradiotherapy (NCRT) and surgery are accepted as treatments for pancreatic ductal adenocarcinoma (PDAC), some authors have highlighted the risks of delaying surgery. Our objective was to analyze the impact of prolonging the t
Autor:
Mauricio Cambeiro, Felipe Angel Calvo Manuel, Rafael Martínez-Monge, Natalia Rodriguez-Spiteri, Luis Isaac Ramos, Luis Pina, Marta Abengozar, Carolina Sobrido Sampedro, Arlette Elizalde, Marta Gimeno Morales, Miguel Angel Idoate, Antonio Esgueva, B. Olartecoechea, Isabel T. Rubio, Fernando Martínez-Regueira
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 12, Iss 6, Pp 521-532 (2020)
Journal of Contemporary Brachytherapy
Journal of Contemporary Brachytherapy
Purpose To evaluate our institutional experience of minimally invasive tumor bed implantation (MITBI) during breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS) to deliver peri-operative high-dose-rate brachytherapy (PHDRBT) as accele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d97ff940a1dbc73a2c4bc21816e17d97
https://www.termedia.pl/Minimally-invasive-tumor-bed-implant-MITBI-and-peri-operative-high-dose-rate-brachytherapy-PHDRBT-for-accelerated-minimal-breast-irradiation-AMBI-or-anticipated-boost-A-PHDRBT-boost-in-breast-conservi,54,42673,1,1.html
https://www.termedia.pl/Minimally-invasive-tumor-bed-implant-MITBI-and-peri-operative-high-dose-rate-brachytherapy-PHDRBT-for-accelerated-minimal-breast-irradiation-AMBI-or-anticipated-boost-A-PHDRBT-boost-in-breast-conservi,54,42673,1,1.html
Autor:
Juan Torres-Melero, Fernando Martínez-Regueira, Isabel Ramos-Bernardo, Israel Manzanedo, Fernando Pereira, Álvaro Arjona, Álvaro Navarro-Barrios, J. Gil-Martínez, Cristóbal Muñoz-Casares, P.A. Cascales-Campos, P. Barrios
Publikováno v:
Surgical Oncology. 33:19-23
Background Endometrial cancer is the most common malignancy of the female genital tract. For cancers detected at an advanced stage or intraperitoneal relapse, the prognosis is poor. Optimal cytoreductive surgery (CRS) is the most accepted treatment;
Autor:
Fernando Rotellar Sastre, Gabriel Zozaya, Fernando Martínez Regueira, Víctor Valentí Azcárate, Luis Hurtado-Pardo, Charles E. Breeze, Pablo Martí-Cruchaga, Fernando Pardo, Alberto Benito, Javier A. Cienfuegos
Publikováno v:
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 114(6)
fifty to 70 percent of pancreatic neuroendocrine tumors are diagnosed incidentally. The objective of this study was to compare the phenotype and oncological outcomes of incidental versus symptomatic pancreatic neuroendocrine tumors.a retrospective st
Autor:
José Gil Martínez, Ángela Casado-Adam, Fernando Pereira, Cristina Rihuete Caro, Ángel Serrano, Estíbalitz Pérez-Viejo, Israel Manzanedo, Gabriel Zozaya, Alfonso García-Fadrique, Xabier Arteaga, Alberto José Gutiérrez Calvo, Adela Petra López García, Álvaro Arjona, P.A. Cascales-Campos, Fernando Martínez Regueira, Remedios Gómez Sanz
Publikováno v:
Annals of Surgical Oncology. 26:2615-2621
Gastric cancer (GC) with peritoneal carcinomatosis (PC) is traditionally considered a terminal stage of the disease. The use of a multimodal treatment, including cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), can b
Autor:
Ricardo Pardo, Rosa Quintana, Antonio Piñero, Carlos Vázquez, Jacobo Cabañas, Fernando Martínez Regueira, Teresa Palomo, Pilar Llamas, Raúl Córdoba, Lorenzo Rabadán, Raquel Barriga, José Mallent, Ander Urruticoetxea, Manel Algara, Ángel Montero, Laia Bernet, María Eugenia Rioja, B. Acea, B. Albi, M. Albi, R. Andrés-Luna, C. Ara, M. Arranz, M. Caba, J. Camps, C. Carcamo, R. Ciérvide, L. Comin, P. Cordeiro, G. De Castro, M. Delgado, M. Durán Poveda, N. Estelles, N. Estrada, E. Fernández, G. Fuster, J. García-Foncillas, I. García, C. García Mur, L. García Pardo, M.A. Gil Olarte, M.T. Gómez, A. González, I. Gutierrez, F. Hernanz, Y. Izarzugaza, J. Jimeno, F. Lobo, D. Martínez, M. Martínez, R. Martínez, P. Matei, J. Masià, S. Menjón, J. Murillo, P. Orihuela, I. Osorio, A. Peña y Lillo, S. Pérez, A. Pinardo, M.A. Piris, M.J. Pla, T. Ramón y Cajal, M. Ramos, T. Ramos, S. Rivas, I. Rodriguez, N. Rodríguez, C. Romero, F. Rojo, J.M. Sanromán, J. Sanz, V. Salvatierra, S. Salido, J.I. Sánchez, J.M. Serra, C. Serrano, M. Socorro, Tejerina Alejandro, Tejerina Antonio, F. Treserra, G. Valadas, M. Vernet, V. Vega, S. Vidal, L. Zarain
Publikováno v:
Revista de Senología y Patología Mamaria. 32:67-74
Resumen El linfoma anaplasico de celulas grandes asociado a implantes mamarios (BIA-ALCL segun sus siglas en ingles) es un tipo raro de linfoma no Hodgkin que se ha descrito en el contexto de la cirugia reconstructiva y estetica de mama mediante impl